Fischi Michael C, Tondato Fernando, Adams Ronnie, Cui Jianhua, Hutchison Michael, Chronos Nicolas A F
Duke University Medical Center, American Cardiovascular Research Institute, 5314 Medlock Corners Drive, Norcross, GA 30092, USA.
J Invasive Cardiol. 2004 Apr;16(4):181-3.
To assess the impact of intraaortic balloon counterpulsation on coronary, renal and aortic blood flow in an animal heart failure model.
Heart failure exacerbations are still often treated with inotropic medications despite a lack of evidence demonstrating any benefit with these drugs. Intraaortic balloon counterpulsation may be considered in certain cases a bridge to recovery.
Four juvenile pigs underwent pacemaker implantation to induce a rapid-pacing mediated dilated cardiomyopathy. After approximately 4 weeks of rapid pacing, the mean ejection fraction was reduced to 28.8+/-9.5% with a mean systolic blood pressure of 64/44 mmHg. The pigs then underwent surgical placement of flow probes around the circumflex coronary artery, renal artery and infrarenal aorta. A Millar catheter was used to calculate Dp/Dt and a Swan-Ganz to calculate cardiac output. Data were recorded at baseline and after 10 minutes of balloon pumping. The pigs were euthanized post-procedure.
Coronary blood flow was increased 9.7% by balloon counterpulsation from 38.3 +/- 12.0 to 42.0+/-11.4 ml/s (p=NS). Renal blood flow was reduced 11.9% by counterpulsation from 130.0+/-88.6 ml/s to 114.5+/-76.6 ml/s (p=NS). Infrarenal aortic blood flow was not changed (mean of 900 ml/s with and without counterpulsation); blood pressure, cardiac output and Dp/Dt were not changed after 10 minutes of pumping. There was little impact observed by changing the position of the balloon closer to or farther away from the apex of the aortic arch.
Intraaortic balloon counterpulsation did not significantly improve hemodynamics in the pig heart failure model. This may be attributed to the high compliance of the juvenile pig's aorta, thus attenuating the pressure wave generated by counterpulsation. A larger volume balloon would merit investigation for this application.
评估主动脉内球囊反搏对动物心力衰竭模型中冠状动脉、肾动脉和主动脉血流的影响。
尽管缺乏证据表明强心药物有任何益处,但心力衰竭加重时仍常使用这些药物进行治疗。在某些情况下,主动脉内球囊反搏可被视为恢复的桥梁。
对4只幼年猪进行起搏器植入以诱导快速起搏介导的扩张型心肌病。快速起搏约4周后,平均射血分数降至28.8±9.5%,平均收缩压为64/44 mmHg。然后对猪进行手术,在左旋冠状动脉、肾动脉和肾下腹主动脉周围放置血流探头。使用Millar导管计算dp/dt,使用Swan-Ganz导管计算心输出量。在基线和球囊泵入10分钟后记录数据。术后对猪实施安乐死。
球囊反搏使冠状动脉血流从38.3±12.0 ml/s增加9.7%至42.0±11.4 ml/s(p=无统计学意义)。反搏使肾血流从130.0±88.6 ml/s减少11.9%至114.5±76.6 ml/s(p=无统计学意义)。肾下腹主动脉血流未改变(反搏前后平均为900 ml/s);泵入10分钟后血压、心输出量和dp/dt未改变。改变球囊离主动脉弓顶端的远近位置观察到的影响很小。
在猪心力衰竭模型中,主动脉内球囊反搏并未显著改善血流动力学。这可能归因于幼年猪主动脉的高顺应性,从而减弱了反搏产生的压力波。对于此应用,更大容积的球囊值得研究。